Abstracts

Level of Alcohol Use and Advanced Hepatic Fibrosis in HIV-Infected and Uninfected Patients

Background: The risk of liver disease associated with level of alcohol consumption is unclear for HIV-infected patients. We evaluated the association between alcohol use categories and advanced hepatic fibrosis by HIV and Hepatitis C virus (HCV) status. Methodology: In HIV-infected and uninfected subjects reporting alcohol use at enrollment in the Veterans Aging Cohort Study, alcohol…

Hepatic Decompensation in HIV/HBV/HCV Patients and the Impact of HBV Therapy

Background: Few studies have compared rates of hepatic decompensation in HIV/HBV/HCV and HIV/HCV patients. It is also unclear if anti-HBV nucleos(t) ide analogue therapy is effective at reducing decompensation rates in triply infected patients. Our objectives were to: 1) compare the incidence rates of hepatic decompensation in HIV/HBV/HCV and HIV/HCV patients, and 2) determine the…

Differential Immune Marker Levels Linked to Liver Fibrosis in HIV/Hepatitis C (HCV) Coinfection

Background: Liver fibrosis, which can lead to cirrhosis and fatal liver failure, advances faster in HIV/HCV co-infected individuals due in part to an elevated inflammatory profile that persists even with effective cART. Immune markers targeting various stages of the fibrosis process could aid in understanding the etiology and prognosis of HIV-HCV co-infection. Methodology: A case-cohort…

Significant Decrease of Liver Fibrosis in HIV-HCV Coinfected Patients Treated for HCV Infection

Background: To evaluate prospectively the regression of liver stiffness and the kinetics of two biochemical tests of liver fibrosis (FIB-4 and APRI) in HIV/HCV co-infected patients treated for their hepatitis C. Methodology: In the ANRS CO13 HEPAVIH Cohort, patients with HIV and chronic hepatitis C who (1) received anti-HCV treatment with pegylated interferon-α and ribavirin…

Is there Long-term Evidence of Advanced Liver Fibrosis after Acute Hepatitis C in HIV Coinfection?

Background: After ten years, the epidemic of sexually transmitted acute hepatitis C (AHC) infection among HIV-seropositive MSM is still ongoing. The rate of early liver fibrosis progression after AHC is of particular interest as more advanced fibrosis progression has been described in small retrospective case series. Here we evaluate the long-term evolution of liver fibrosis…

Outcome of 215 HCV/HIV-Coinfected Liver Transplant Recipients: A Prospective Multicenter Study

Background: We compared the survival after liver transplantation (LT) between HCV/HIV-coinfected patients and HCV-monoinfected patients. We also identified prognostic factors in HCV/HIV-coinfected LT recipients. Methodology: Consecutive 215 HCV/HIV-coinfected patients who underwent LT between 2002 and 2012 and followed until June 2013 at 22 Spanish centers were matched with 613 HCV-monoinfected patients who received LT during…